Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)

CompletedOBSERVATIONAL
Enrollment

8,380

Participants

Timeline

Start Date

May 19, 2020

Primary Completion Date

January 26, 2021

Study Completion Date

December 1, 2024

Conditions
Coronavirus InfectionCOVID-19
Interventions
DIAGNOSTIC_TEST

Point-of-care test for SARS-CoV-2

Throat and nose swabs and/or saliva samples and/or whole blood and/or finger stick samples may be taken to be tested on Point-of-care tests for SARS-CoV-2

Trial Locations (15)

Unknown

Sandwell General Hospital Birmingham NHS Trust, Birmingham

University Hospitals of Derby and Burton NHS FT, Derby

Frimley Health NHS FT, Frimley

Airedale NHS FT, Keighley

Leeds Teaching Hospital NHS FT, Leeds

St George's University Hospitals NHS FT, London

Newcastle upon Tyne Hospitals NHS FT, Newcastle upon Tyne

Nottingham University Hospitals NHS Trust, Nottingham

Oxford University Hospitals NHS FT, Oxford

Royal Berkshire Hospital NHS FT, Reading

Barking, Havering & Redbridge Hospitals NHS FT, Romford

Salford Royal NHS FT, Salford

University Hospital Southampton NHS FT, Southampton

University Hospitals of North Midlands NHS Trust, Stoke-on-Trent

M13 9WU

Manchester University NHS FT, Manchester

All Listed Sponsors
lead

Manchester University NHS Foundation Trust

OTHER_GOV

NCT04408170 - Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19) | Biotech Hunter | Biotech Hunter